Malignant lymphomas in children and adolescents: Practical knowledge for diagnosis;Maligne Lymphome im Kindes- und Jugendalter: Praktisches Wissen für den diagnostischen Alltag

Pathologe

Volumn 35, Issue 4, 2014, Pages 383-397

  Oschlies, I ^a   Klapper, W ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

ALK1; Anaplastic large cell lymphoma; Burkitt lymphoma; Immunohistochemistry; Lymphoblastic lymphoma; Pediatric lymphoma

Indexed keywords

TUMOR MARKER;

ADOLESCENT; AGE; CHILD; CLASSIFICATION; COOPERATION; DIFFERENTIAL DIAGNOSIS; HUMAN; IMMUNOHISTOCHEMISTRY; INTERDISCIPLINARY COMMUNICATION; LYMPHOMA; PATHOLOGY; PATIENT REFERRAL; PROGNOSIS;

ADOLESCENT; AGE FACTORS; CHILD; COOPERATIVE BEHAVIOR; DIAGNOSIS, DIFFERENTIAL; HUMANS; IMMUNOHISTOCHEMISTRY; INTERDISCIPLINARY COMMUNICATION; LYMPHOMA; PROGNOSIS; REFERRAL AND CONSULTATION; TUMOR MARKERS, BIOLOGICAL;

EID: 84905440106     PISSN: 01728113     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00292-014-1891-5     Document Type: Article

References (18)

1. Swerdlow SH, Campo E, Harris N et al (2008) WHO classification of tumors of the haematopoietic and lymphoid tissues. IARC, Lyon
2. Burkhardt B, Oschlies I, Klapper W et al (2010) Non-Hodgkin's lymphoma in adolescents: experiences in 378 adolescent NHL patients treated according to pediatric NHL-BFM protocols. Leukemia 25:153-160
3. Oschlies I, Salaverria I, Mahn F et al (2009) Pediatric follicular lymphoma - a clinico-pathological study of a population-based series of patients treated within the NHL-BFM (Berlin-Frankfurt-Munster) multicenter trials. Haematologica 95:253-259
4. Rizzo KA, Streubel B, Pittaluga S et al (2010) Marginal zone lymphomas in children and the young adult population; characterization of genetic aberrations by FISH and RT-PCR. Mod Pathol 23:866-873
5. Hartmann S, Cogliatti S, Hansmann ML (2013) Nodular lymphocyte- predominant Hodgkin's lymphoma and differential diagnoses. Pathologe 34:233-243
6. Oschlies I, Burkhardt B, Chassagne-Clement C et al (2011) Diagnosis and immunophenotype of 188 pediatric lymphoblastic lymphomas treated within a randomized prospective trial: experiences and preliminary recommendations from the European childhood lymphoma pathology panel. Am J Surg Pathol 35:836-844
7. Meinhardt A, Burkhardt B, Zimmermann M et al (2010) Phase II window study on rituximab in newly diagnosed pediatric mature B-cell non-Hodgkin's lymphoma and Burkitt leukemia. J Clin Oncol 28:3115-3121
8. Barth MJ, Goldman S, Smith L et al (2013) Rituximab pharmacokinetics in children and adolescents with de novo intermediate and advanced mature B-cell lymphoma/leukaemia: a Children's Oncology Group report. Br J Haematol 162:678-683
9. Oschlies I, Klapper W, Zimmermann M et al (2006) Diffuse large B-cell lymphoma in pediatric patients belongs predominantly to the germinal-center type B-cell lymphomas: a clinicopathologic analysis of cases included in the German BFM (Berlin-Frankfurt-Munster) multicenter trial. Blood 107:4047-4052
10. Klapper W, Szczepanowski M, Burkhardt B et al (2008) Molecular profiling of pediatric mature B-cell lymphoma treated in population-based prospective clinical trials. Blood 112:1374-1381
11. Iqbal J, Sanger WG, Horsman DE et al (2004) BCL2 translocation defines a unique tumor subset within the germinal center B-cell-like diffuse large B-cell lymphoma. Am J Pathol 165:159-166
12. Klapper W (2013) Border between reactive and neoplastic lymphoproliferative processes. Pathologe 34:185
13. Hartmann S, Hansmann ML (2013) Lymph node pathology - an update. Pathologe 34:34-44
14. Kuppers R, Engert A, Hansmann ML (2012) Hodgkin lymphoma. J Clin Invest 122:3439-3447
15. Lamant L, McCarthy K, d'Amore E et al (2011) Prognostic impact of morphologic and phenotypic features of childhood ALK-positive anaplastic large-cell lymphoma: results of the ALCL99 study. J Clin Oncol 29:4669-4676
16. Damm-Welk C, Busch K, Burkhardt B et al (2007) Prognostic significance of circulating tumor cells in bone marrow or peripheral blood as detected by qualitative and quantitative PCR in pediatric NPM-ALK positive anaplastic large cell lymphoma. Blood 110:670-677
17. Woessmann W, Zimmermann M, Lenhard M et al (2011) Relapsed or refractory anaplastic large-cell lymphoma in children and adolescents after Berlin-Frankfurt-Muenster (BFM)-type first-line therapy: a BFM-group study. J Clin Oncol 29:3065-3071
18. Damm-Welk C, Klapper W, Oschlies I et al (2009) Distribution of NPM1-ALK and X-ALK fusion transcripts in paediatric anaplastic large cell lymphoma: a molecular-histological correlation. Br J Haematol 146:306-309